📰 Optune Lua News
Page 6 - Optune Lua News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Optune Lua. Real-time updates on events, politics, business and more.
August 29, 2023
-- NovoCure has an average rating of outperform and price targets ranging from $23 to $49, according to analysts polled by Capital IQ. Price: 20.43, Change: +1.83, Percent Change: +9.81 ...
August 28, 2023
Unraveling the Factors That Could Limit NovoCure Ltd's Future Growth
August 28, 2023
Unpacking the Financial Health of NovoCure (NVCR) and its Potential Risks
August 27, 2023
Shares of NovoCure Limited (NASDAQ:NVCR – Get Free Report) have been given a consensus rating of “Moderate Buy” by the nine analysts that are presently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, one has issued a hold rating and seven have issued a buy rating on […]
August 21, 2023
StockNews.com started coverage on shares of NovoCure (NASDAQ:NVCR – Free Report) in a research report report published on Thursday. The brokerage issued a sell rating on the medical equipment provider’s stock. Several other brokerages have also recently issued reports on NVCR. SVB Securities started coverage on NovoCure in a research report on Friday, August 4th. […]
August 18, 2023
California State Teachers Retirement System trimmed its holdings in shares of NovoCure Limited (NASDAQ:NVCR – Free Report) by 0.9% during the 1st quarter, Holdings Channel reports. The fund owned 161,322 shares of the medical equipment provider’s stock after selling 1,537 shares during the period. California State Teachers Retirement System’s holdings in NovoCure were worth $9,702,000 […]
August 17, 2023
A number of firms have modified their ratings and price targets on shares of NovoCure (NASDAQ: NVCR) recently: 8/17/2023 – NovoCure is now covered by analysts at StockNews.com. They set a “sell” rating on the stock. 8/8/2023 – NovoCure was upgraded by analysts at Piper Sandler from a “neutral” rating to an “overweight” rating. They […]
August 10, 2023
BNP PARIBAS ASSET MANAGEMENT Holding S.A. lowered its holdings in shares of NovoCure Limited (NASDAQ:NVCR – Free Report) by 2.9% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 107,396 shares of the medical equipment provider’s stock after selling 3,246 shares during […]
August 10, 2023
NovoCure Limited (NASDAQ:NVCR – Get Free Report)’s stock price traded up 6.4% on Thursday . The stock traded as high as $31.81 and last traded at $31.50. 362,423 shares changed hands during trading, a decline of 69% from the average session volume of 1,183,357 shares. The stock had previously closed at $29.61. Analyst Ratings Changes […]
August 9, 2023
Leerink Partnrs reissued their outperform rating on shares of NovoCure (NASDAQ:NVCR – Free Report) in a research report released on Friday, PriceTargets.com reports. NVCR has been the subject of a number of other research reports. SVB Securities initiated coverage on shares of NovoCure in a research report on Friday. They issued an outperform rating and […]